Data / Form D filings / Altis Biosystems, Inc.
Altis Biosystems, Inc.: Form D filings
Altis Biosystems, Inc., a biotechnology company in Durham, NC, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on April 7, 2025, reports $2.1 million sold of a $2.3 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6 DAVIS DRIVE, SUITE 159, Durham, NC, 27709
- Phone
- (516) 255-7290
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1799892
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | New notice | $2,250,000 | $2,126,307 | $123,693 | 9 | Mar 31, 2025 | sec.gov |
| Aug 2, 2022 | New notice | $5,000,000 | $1,363,658 | $3,636,342 | 17 | Jul 20, 2022 | sec.gov |
| Jul 22, 2020 | Amendment | $3,103,069 | $3,103,069 | 42 | Dec 30, 2019 | sec.gov | |
| Jan 17, 2020 | New notice | $2,196,595 | $938,592 | $1,258,003 | 7 | Dec 30, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Perkins | Director | |
| Michael Dial | Director | |
| Christopher Sims | Executive Officer | |
| Benjamin Scruggs | Executive Officer, Director | |
| Jimmy Smedley | Executive Officer | |
| Susan Mahony | Director | |
| Kevin Causey | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Apr 7, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Altis Biosystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.